Shiu M H, Papacristou D N, Kosloff C, Eliopoulos G
Ann Surg. 1980 Dec;192(6):730-7. doi: 10.1097/00000658-198012000-00007.
Pathoanatomic studies of the regional spread of adenocarcinoma of the middle one-third of the stomach suggested the need for extensive gastric and lymphatic resection. To seek evidence of improved results, a retrospective study was made of 213 patients curatively treated by three commonly used procedures: 1) radical high subtotal gastrectomy (SG, n = 39), 2) radical total gastrectomy (TG, n = 48), and 3) extended total gastrectomy (ETG, n = 126). The overall five-year survival rates were SG:10%, TG:16%, and ETG:19%. Advanced stage tumors (N2, N3, or M1) were highly lethal, irrespective of the type of resection. However, patients with early stage tumors (T1-4, N0 or N1) showed higher survival rates after more extensive resections (ETG:42% and TG: six of eight patients, versus SG:17%). The highest survival rate (93%) was observed in a subset of patients with early stage tumors electively treated by ETG; this was achieved despite the presence of metastasis to the juxtagastric (N1) lymph nodes or direct invasion of an adjacent organ in most of these patients. These observations confirm the merit of extensive resection for carcinoma of the midstomach.
胃中三分之一腺癌区域扩散的病理解剖学研究表明,需要进行广泛的胃和淋巴结切除。为了寻找疗效改善的证据,对213例接受三种常用手术治愈性治疗的患者进行了回顾性研究:1)根治性高位次全胃切除术(SG,n = 39),2)根治性全胃切除术(TG,n = 48),以及3)扩大全胃切除术(ETG,n = 126)。总体五年生存率分别为SG:10%,TG:16%,ETG:19%。晚期肿瘤(N2、N3或M1)具有高度致死性,与切除类型无关。然而,早期肿瘤(T1-4,N0或N1)患者在接受更广泛切除后生存率更高(ETG:42%,TG:8例患者中有6例,而SG:17%)。在接受ETG选择性治疗的早期肿瘤患者亚组中观察到最高生存率(93%);尽管这些患者中的大多数存在胃周(N1)淋巴结转移或邻近器官直接侵犯,但仍实现了这一生存率。这些观察结果证实了胃中部癌广泛切除的优点。